Literature DB >> 14623275

Reverse transformation of hepatic myofibroblast-like cells by TGFbeta1/LAP.

Masato Isono1, Mariko Soda, Asuka Inoue, Hideo Akiyoshi, Kenzo Sato.   

Abstract

The activation of hepatic stellate cells (HSCs) to myofibroblasts (MFBs) is a key process for initiation of hepatic fibrosis and accumulation of the extracellular matrix (ECM). In this process, transforming growth factor beta1 (TGFbeta1) plays an important role in activating HSCs. In this study, we determined whether the activation of HSC was suppressed by latency-associated peptide (LAP) that is a part of TGFbeta1 precursor peptide. An MFB-like cell line (MFBY2) established from a fibrotic rat liver was infected with a recombinant adenovirus expressing LAP (AxCALAP). As results, AxCALAP-infected MFBY2 arrested cell proliferation and significantly decreased in expression of TGFbeta1 and ECM components. Interestingly, the expression of glial fibrillary acidic protein and up-take of retinoic acid were enhanced by AxCALAP-infection, while expression of alpha-smooth muscle actin was inhibited. These results suggested that overexpression of LAP in MFBs induces the reverse transformation to HSC phenotype. The adenoviral vector used in this study may have possible therapeutic applications in liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623275     DOI: 10.1016/j.bbrc.2003.10.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.

Authors:  Ashley M Lakner; Nury M Steuerwald; Tracy L Walling; Sriparna Ghosh; Ting Li; Iain H McKillop; Mark W Russo; Herbert L Bonkovsky; Laura W Schrum
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

2.  Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-beta signaling.

Authors:  Yuan-Wen Chen; Jian-Xin Wu; Ying-Wei Chen; Ding-Guo Li; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

3.  A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells.

Authors:  Alessandro Federico; Valeria Conti; Giusy Russomanno; Marcello Dallio; Mario Masarone; Paola Stiuso; Concetta Tuccillo; Michele Caraglia; Valentina Manzo; Marcello Persico; Amelia Filippelli; Carmelina Loguercio
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

4.  Genetic Characterization of Rat Hepatic Stellate Cell Line HSC-T6 for In Vitro Cell Line Authentication.

Authors:  Indrajit Nanda; Claus Steinlein; Thomas Haaf; Eva M Buhl; Domink G Grimm; Scott L Friedman; Steffen K Meurer; Sarah K Schröder; Ralf Weiskirchen
Journal:  Cells       Date:  2022-05-29       Impact factor: 7.666

Review 5.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

6.  Adipose-derived stem cells alleviate liver injury induced by type 1 diabetes mellitus by inhibiting mitochondrial stress and attenuating inflammation.

Authors:  Yanli Hou; Wenyu Ding; Peishan Wu; Changqing Liu; Lina Ding; Junjun Liu; Xiaolei Wang
Journal:  Stem Cell Res Ther       Date:  2022-04-01       Impact factor: 6.832

Review 7.  Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?

Authors:  Jens Herrmann; Axel M Gressner; Ralf Weiskirchen
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.